Form 4: Ionis Pharmaceuticals Executive Sells Shares
Insider Transaction (Form 4)
Shannon L. Devers, EVP, Chief Human Resources Ofc of Ionis Pharmaceuticals Inc, sold 1,357 shares of common stock on October 15, 2026 for $43.54 per share.
Summary
- Option exercise/conversion: acquired 2,820 Common Stock on October 15, 2026; holds 19,168 after (Direct).
- Open-market sale: disposed of 1,357 Common Stock at $43.54 ($59,082) on October 16, 2026; holds 17,811 after (Direct).
- Option exercise/conversion: disposed of 2,820 Restricted Stock Unit on October 15, 2026; holds 49,884 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $59,082 of stock on the open market.
Insider Transactions
Shannon L. Devers — Officer (EVP, Chief Human Resources Ofc)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-15 | Option exercise/conversion | Common Stock | 2,820 | — | — | 19,168 |
| 2026-10-16 | Open-market sale | Common Stock | 1,357 | $44 | $59.1K | 17,811 |
| 2026-10-15 | Option exercise/conversion | Restricted Stock Unit | 2,820 | — | — | 49,884 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-15 | Option exercise/conversion (2,820 shares) |
| 2026-10-16 | Open-market sale (1,357 shares) |
| 2026-10-15 | Option exercise/conversion (2,820 shares) |
Keywords
insider transaction, Form 4, IONS, IONIS PHARMACEUTICALS INC, bearish, Shannon L. Devers
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.